These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 3509796

  • 1. Serum osteocalcin, bone alkaline phosphatase isoenzyme and plasma tartrate resistant acid phosphatase in patients on chronic maintenance hemodialysis.
    Stĕpán JJ, Lachmanová J, Straková M, Pacovský V.
    Bone Miner; 1987 Nov; 3(2):177-83. PubMed ID: 3509796
    [Abstract] [Full Text] [Related]

  • 2. Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism.
    Stĕpan JJ, Silinková-Málková E, Havránek T, Formánková J, Zichová M, Lachmanová J, Straková M, Broulik P, Pacovský V.
    Clin Chim Acta; 1983 Sep 30; 133(2):189-200. PubMed ID: 6627682
    [Abstract] [Full Text] [Related]

  • 3. Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism.
    Stĕpán JJ, Presl J, Broulík P, Pacovský V.
    J Clin Endocrinol Metab; 1987 May 30; 64(5):1079-82. PubMed ID: 3031119
    [Abstract] [Full Text] [Related]

  • 4. Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome.
    Stĕpán JJ, Musilová J, Pacovský V.
    J Bone Miner Res; 1989 Apr 30; 4(2):193-8. PubMed ID: 2786321
    [Abstract] [Full Text] [Related]

  • 5. [Osteocalcin in chronic hemodialysis patients as an additional parameter in the diagnosis of advanced secondary hyperparathyroidism].
    Motz W.
    Acta Med Austriaca; 1989 Apr 30; 16(1):8-12. PubMed ID: 2785325
    [Abstract] [Full Text] [Related]

  • 6. [Serum levels of the tartrate-resistant isoenzyme, acid phosphatase, for the evaluation of bone remodeling in hyperthyroidism].
    Legovini P, De Menis E, Da Rin G, Roiter I, Breda F, Conte N.
    Minerva Endocrinol; 1994 Sep 30; 19(3):133-8. PubMed ID: 7799895
    [Abstract] [Full Text] [Related]

  • 7. Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism.
    Stĕpán JJ, Mikulecký M, Bek V, Broulík P, Pacovský V.
    Neoplasma; 1989 Sep 30; 36(4):495-501. PubMed ID: 2770935
    [Abstract] [Full Text] [Related]

  • 8. [Acute effects of hemodialysis on circulating parathormone, osteocalcin and alkaline phosphatase in patients with chronic renal failure].
    Broulík P, Hrubý M.
    Cas Lek Cesk; 1993 Nov 22; 132(22):681-3. PubMed ID: 8293434
    [Abstract] [Full Text] [Related]

  • 9. [Osteocalcin, a marker in diseases with elevated bone metabolism].
    Stracke H, Schatz C, Pralle H, Ullmann J, Schatz H.
    Dtsch Med Wochenschr; 1985 Sep 20; 110(38):1442-6. PubMed ID: 3875469
    [Abstract] [Full Text] [Related]

  • 10. Serum osteocalcin levels in normal subjects and patients with primary hyperparathyroidism.
    Ljunghall S, Hällgren R, Rastad J.
    Exp Clin Endocrinol; 1985 Dec 20; 86(2):218-22. PubMed ID: 3879222
    [Abstract] [Full Text] [Related]

  • 11. Early changes of bone histology and circulating markers of bone turnover after parathyroidectomy in hemodialysis patients with severe hyperparathyroidism.
    Yajima A, Tanaka K, Tominaga Y, Ogawa Y, Tanizawa T, Inou T, Otsubo O, Otsubo K.
    Clin Nephrol; 2001 Jul 20; 56(1):27-34. PubMed ID: 11499656
    [Abstract] [Full Text] [Related]

  • 12. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.
    Charles P, Poser JW, Mosekilde L, Jensen FT.
    J Clin Invest; 1985 Dec 20; 76(6):2254-8. PubMed ID: 3878367
    [Abstract] [Full Text] [Related]

  • 13. [Osteocalcin].
    Galli M, Caniggia M.
    Minerva Med; 1984 Nov 03; 75(42):2489-501. PubMed ID: 6334818
    [Abstract] [Full Text] [Related]

  • 14. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients.
    Bozkaya G, Nart A, Uslu A, Onman T, Aykas A, Doğan M, Karaca B.
    Transplant Proc; 2008 Nov 03; 40(1):151-5. PubMed ID: 18261573
    [Abstract] [Full Text] [Related]

  • 15. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH, Huang TS, Hsieh SJ.
    Miner Electrolyte Metab; 1996 Nov 03; 22(4):219-23. PubMed ID: 8807625
    [Abstract] [Full Text] [Related]

  • 16. Serum levels of bone Gla-protein in normal humans and in patients with chronic renal failure.
    Sugimoto K, Dohi Y, Dohi K, Yonemasu K, Fujimoto J, Kanauchi M, Yamanaka F, Moriyama T, Ishikawa H.
    Miner Electrolyte Metab; 1987 Nov 03; 13(3):152-7. PubMed ID: 3498115
    [Abstract] [Full Text] [Related]

  • 17. Serum osteocalcin in primary hyperparathyroidism: short-term effect of surgery.
    Minisola S, Scarnecchia L, Scarda A, Bigi F, Tabolli S, Valtorta C, Mazzuoli G.
    Miner Electrolyte Metab; 1988 Nov 03; 14(4):201-7. PubMed ID: 3264876
    [Abstract] [Full Text] [Related]

  • 18. Influence of the hepatocellular damage on the clinical usefulness of biochemical markers of bone metabolism and parathormon in haemodialysed patients.
    Jaroszyński AJ, Ksiazek A, Załuska W.
    Med Sci Monit; 2002 Sep 03; 8(9):CR652-6. PubMed ID: 12218948
    [Abstract] [Full Text] [Related]

  • 19. [Clinical evaluation of osteocalcin in chronic hemodialysis patients].
    Nishio S, Hayashi S, Yoshihara H, Kobayagawa H.
    Hinyokika Kiyo; 1989 Nov 03; 35(11):1839-45. PubMed ID: 2618881
    [Abstract] [Full Text] [Related]

  • 20. The activity of the bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion in premenopausal and postmenopausal women with primary hyperparathyroidism.
    Broulik PD, Stĕpán J, Pacovský V.
    Exp Clin Endocrinol; 1984 May 03; 83(3):315-9. PubMed ID: 6540700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.